These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32732858)

  • 81. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Naoumov NV; Lopes AR; Burra P; Caccamo L; Iemmolo RM; de Man RA; Bassendine M; O'Grady JG; Portmann BC; Anschuetz G; Barrett CA; Williams R; Atkins M
    J Hepatol; 2001 Jun; 34(6):888-94. PubMed ID: 11451173
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Abdelmessih R; Verna EC; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2012 Jul; 18(7):834-8. PubMed ID: 22422699
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical evidence for hepatitis B transmission resulting from corneal transplantation.
    Hoft RH; Pflugfelder SC; Forster RK; Ullman S; Polack FM; Schiff ER
    Cornea; 1997 Mar; 16(2):132-7. PubMed ID: 9071524
    [TBL] [Abstract][Full Text] [Related]  

  • 86. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.
    Krogsgaard K; Wantzin P; Aldershvile J; Kryger P; Andersson P; Nielsen JO
    J Infect Dis; 1986 Feb; 153(2):298-303. PubMed ID: 3944482
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL; Jou JH; Said A
    Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Choudhary NS; Saraf N; Saigal S; Mohanka R; Rastogi A; Goja S; Menon PB; Soin AS
    Transpl Infect Dis; 2015 Jun; 17(3):329-33. PubMed ID: 25682715
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
    Ben-Ari Z; Mor E; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2003 Mar; 35(2):609-11. PubMed ID: 12644066
    [No Abstract]   [Full Text] [Related]  

  • 93. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
    Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
    Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?
    Anwar N; Sherman KE
    J Viral Hepat; 2018 Oct; 25(10):1110-1115. PubMed ID: 29968277
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach.
    Mohrbach J; Janssen MW; Heine GH; Gärtner BC; Fliser D; Sester M; Sester U
    J Clin Virol; 2010 Sep; 49(1):53-7. PubMed ID: 20656549
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients.
    Leung DH; Ton-That M; Economides JM; Healy CM
    Am J Transplant; 2015 Feb; 15(2):535-40. PubMed ID: 25611886
    [TBL] [Abstract][Full Text] [Related]  

  • 98. When can it be useful to look for occult HBV in hemodialysis patients?
    Ruiz-Calero Cendrero RM; Cancho Castellano B; Martín Hidalgo-Barquero MV; Cid Parra MC; Galán González J; Fernández Solís MA; Sánchez García O
    Nefrologia (Engl Ed); 2020; 40(2):115-119. PubMed ID: 31551120
    [No Abstract]   [Full Text] [Related]  

  • 99. Utilization of hepatitis B core antibody-positive donor liver grafts.
    MacConmara MP; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Chapman WC; Doyle MB
    HPB (Oxford); 2012 Jan; 14(1):42-8. PubMed ID: 22151450
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.
    Burton JR; Terrault NA; Goldberg DS; Bloom RD; Gilroy R; Heimbach JK; Brown RS; Everson GT; Rubin E; Wiesner R; Pomfret EA
    Transplantation; 2020 Mar; 104(3):476-481. PubMed ID: 31634329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.